HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) co-founder and CEO Dr. Jason Mitchell and chief corporate officer Danny Brody were featured on a recent segment of the Cannabis Investing Podcast. The program provides actionable investment insight, context with which to understand the burgeoning cannabis industry, and interviews with C-level executives, scientists, law and sector experts. During their segment, Mitchell and Brody discussed highlights in the cannabis industry, including the recent multibillion deal between GW Pharma and Jazz Pharmaceuticals, as well as radical transparency, the industry’s methodical growth and how companies can become more efficient during COVID-19. They also discussed what makes HempFusion distinctive among other companies operating in the market and prospects of the company going public. From the beginning, HempFusion was committed to compliance, which was a different approach than others operating in the space. That commitment has served the company as the industry has grown and become more regulated; HempFusion is now ahead of the game because it is already compliant. The two also discussed the company’s future strategic plan. Mitchell noted that HempFusion is a completely science-backed company with patented products and proprietary delivery methods, very similar to GW Pharma. “The big fish are now circling,” said HempFusion Wellness co-founder and CEO Dr. Jason Mitchell during the show.
To listen to the podcast, visit https://cnw.fm/Pt08O
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion
About CanadianCannabisWire
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CanadianCannabisWire.com
Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com